0000898432-24-000011.txt : 20240103
0000898432-24-000011.hdr.sgml : 20240103
20240103163604
ACCESSION NUMBER: 0000898432-24-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Gautam
CENTRAL INDEX KEY: 0001738054
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 24507247
MAIL ADDRESS:
STREET 1: C/O AMNEAL PHARMACEUTICALS LLC
STREET 2: 400 CROSSING BLVD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
form4.xml
X0508
4
2024-01-01
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001738054
Patel Gautam
C/O AMNEAL PHARMACEUTICALS LLC
400 CROSSING BLVD
BRIDGEWATER
NJ
08807
true
false
Class A Common Stock
2024-01-01
4
J
0
33458067
D
374318
D
Class A Common Stock
2024-01-01
4
G
0
1598115
0
A
1972433
D
The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee.
The reporting person is a beneficiary of one of the Trusts. Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer.
/s/ Gautam Patel
2024-01-03